Storys aus Germany

Acousia Therapeutics GmbH

Acousia Therapeutics Reaches 50% Patient Enrollment Milestone in Phase 2 PROHEAR Study

Tübingen, Germany (ots) - Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study, evaluating ACOU085 (INN: bimokalner) for the prevention of cisplatin-induced hearing loss in patients with testicular cancer undergoing chemotherapy. Cisplatin is a cornerstone in modern oncology and ...

Grünenthal Group

Apotex licenses exclusive Canadian rights to Qutenza® from Grünenthal

Aachen, Germany & Toronto, Canada, (ots) - Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, announced today that they have entered into a strategic licensing agreement whereby Apotex will have the exclusive Canadian rights to Qutenza®, a topical, non-systemic, ...

Grünenthal Group

Grünenthal appoints Prof. Dr. Uli Brödl as Chief Scientific Officer

Northern Data Group

Northern Data Group to Develop Best-in-Class U.S. Data Center for High Performance Computing

Frankfurt, Germany (ots/PRNewswire) - - Expanding portfolio to meet the demand for AI and High-Performance Computing (HPC) solutions - Expected to deliver 120MW in the near-term with capacity to expand up to 180MW - Data center to create up to 100 new jobs and support local economy Northern Data AG (ETR: NB2) ('Northern Data Group' or 'the Group'), a leading provider ...

Exyte

Exyte Receives Micron's Outstanding Supplier Performance Award in Supplier Diversity

Stuttgart, Germany (ots/PRNewswire) - Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, was presented with the Outstanding Supplier Performance Award in Supplier Diversity at the Micron Supplier Day 2024. The event, held in San Francisco, CA, USA, was attended by top-level management of Micron and its suppliers, including Exyte. ...

Grünenthal Group

Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain

Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...

Grünenthal Group

First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist

Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...

Grünenthal Group

Grünenthal appoints Dr. Jan Adams as Chief Commercial Officer

Aachen, Germany (ots) - Grünenthal announced today that Jan Adams, M.D., currently Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will assume the role of Chief Commercial Officer (CCO) effective 1 October 2024. Prior to his role as CSO, he was Head of Strategy and Portfolio at Grünenthal. Jan Adams has over two decades of experience in the pharmaceutical and healthcare industry. Since ...

KIA Europe

Kia Charge: the smartest way to charge your Kia now has 800,000 charging points

Frankfurt, Germany (ots/PRNewswire) - - Kia Charge offers access across Europe to more than 800,000 charging points, a 10% increase on Q2 2024 and a 39% on Q2 2023 - Kia Charge enables Kia customers to easily charge their vehicle with a one-stop charging solution - 41% of customers have registered into Kia Charge in 2024 Kia Charge is the company's one-contract service ...

KIA Europe

Kia OTA update adds SoundCloud and enhances EV Route Planner and voice control

Frankfurt, Germany (ots/PRNewswire) - - The latest Kia over-the-air (OTA) update includes music streaming from SoundCloud and improvements to planning EV charging - Update has more than 150 changes, with additional voice commands enhancing the in-car experience - Driver speed assistance warning can be turned off using the mute button at the steering wheel ...

INFOSYS

Infosys Collaborates with Clearstream, Part of Deutsche Börse, to Enhance Digital Issuance Platform to Simplify Securities Issuance and Servicing

Frankfurt, Germany and Bengaluru, India (ots/PRNewswire) - Successfully enhanced the D7 platform to accelerate time-to-market for exchange group's customers and improve their profitability Infosys (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, today ...

Ledvance

ams OSRAM and LEDVANCE extend global brand partnership into the next decade

Acousia Therapeutics GmbH

Acousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences

Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...

Grünenthal Group

Grünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®

Aachen, Germany (ots) - - Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal’s footprint in the United States. - With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). - Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly ...

Grünenthal Group

Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients

Aachen, Germany (ots) - - Investment of more than €80 million to modernise Latin American production sites. - In Santiago de Chile, a 3,500-square-metre solids plant has been completely refurbished, creating a world-class manufacturing facility with a production capacity of 1.8 billion tablets annually. - In ...

Lifespin GmbH

Lifespin GmbH and Acıbadem Forge a Groundbreaking Metabolomics Partnership to Advance Personalized Medicine

Istanbul and Regensburg, Germany (ots/PRNewswire) - lifespin GmbH, a pioneer in health status detection software, has teamed up with Acıbadem University (ACU) and Acıbadem Healthcare Group (AHG) to launch a comprehensive precision medicine initiative, a significant stride towards revolutionizing personalized ...

INFOSYS

Infosys and Handelsblatt Media Group Announce Strategic Collaboration

Düsseldorf, Germany (ots/PRNewswire) - To make complex reports on global economic and finance issues more accessible and easily consumable for the public leveraging generative AI Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced a strategic collaboration with the Handelsblatt Media Group, ...

Geekplus Europe GmbH

Geekplus to showcase mobile robot order fulfillment innovations during LogiMAT trade show

Düsseldorf, Germany (ots/PRNewswire) - Geekplus, the global leader in mobile robot and smart logistics solutions, is celebrating is celebrating innovation and growth in the European market during the LogiMAT supply chain trade show in Stuttgart. Since establishing offices in Dusseldorf in 2019, the company has brought its comprehensive suite of Goods-To-Person ...

Acousia Therapeutics GmbH

Hearing loss company Acousia announces first patient enrolled in its Phase 2 PROHEAR-Study

Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first patient for the PROHEAR-Study. The PROHEAR-Study is a placebo-controlled, Phase 2a study with split-body design, which investigates the otoprotective efficacy ...

Henkel AG & Co. KGaA

Henkel introduces fully paid gender-neutral parental leave for its employees worldwide

Grünenthal Group

BehaVR and Fern Health Merge To Form RealizedCare, Launch Digital Care Management Platform to Unlock the Value of Digital Therapeutics

NASHVILLE, Tenn., Aachen, Germany (ots) - The merger will accelerate a new digitally-powered care management solution for chronic pain and beyond; Pharmaceutical company Grünenthal becomes the largest investor in the combined enterprise BehaVR, a pioneering force in digital therapeutics (DTx) experiences, and Fern ...

Deutschland Museum DM GmbH

High praise for the newest addition to the German museum landscape / Deutschlandmuseum receives THEA Award

Berlin, Germany (ots) - The unique approach pioneered by the Deutschlandmuseum of providing an immersive visitor experience has generated worldwide attention. Now, the Deutschlandmuseum has been honoured with the THEA Award for Outstanding Achievement, informally known as the ‘Oscar of the entertainment sector’. ...

Acousia Therapeutics GmbH

Hearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial

Tübingen, Germany (ots/PRNewswire) - Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic forms of hearing loss, received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic ...

Acousia Therapeutics GmbH

Hearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial

Tübingen, Germany (ots) - Acousia Therapeutics, a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the prevention and treatment of acute and chronic forms of hearing loss, received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic otoprotectant ...